PT  - JOURNAL ARTICLE
AU  - Review Team
AU  - Llinos Haf Spencer
AU  - Ned Hartfiel
AU  - Annie Hendry
AU  - Bethany Anthony
AU  - Abraham Makanjuola
AU  - Report Team
AU  - Nathan Bray
AU  - Dyfrig Hughes
AU  - Clare Wilkinson
AU  - Deb Fitzsimmons
AU  - Rhiannon Tudor Edwards
TI  - Have infection control and prevention measures resulted in any adverse outcomes for care home and domiciliary care residents and staff?
AID  - 10.1101/2022.05.04.22274657
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.05.04.22274657
4099  - http://medrxiv.org/content/early/2022/05/05/2022.05.04.22274657.short
4100  - http://medrxiv.org/content/early/2022/05/05/2022.05.04.22274657.full
AB  - What is a Rapid Review?Our rapid reviews use a variation of the systematic review approach, abbreviating or omitting some components to generate the evidence to inform stakeholders promptly whilst maintaining attention to bias. They follow the methodological recommendations and minimum standards for conducting and reporting rapid reviews, including a structured protocol, systematic search, screening, data extraction, critical appraisal and evidence synthesis to answer a specific question and identify key research gaps. They take 1-2 months, depending on the breadth and complexity of the research topic/question(s), the extent of the evidence base and type of analysis required for synthesis.Background / Aim of Rapid Review Care for older and vulnerable people must sustain core infection prevention and control (IPC) practices and remain vigilant for COVID-19 transmission to prevent virus spread and protect residents and healthcare professionals from severe infections, hospitalisations and death.However, these measures could potentially lead to adverse outcomes such as decreased mental wellbeing in patients and staff. A recent publication by Public Health England examines the effectiveness of IPC practices for reducing COVID-19 transmission in care homes (Duval et al., 2021). We explore evidence relating to adverse outcomes from IPC practices to help inform policy recommendations and identify gaps within the literature where further research can be prioritised.Extent of the evidence base15 studies were identified: 14 primary studies and one rapid reviewRecency of the evidence baseOf the primary studies, six were published in 2020 and eight were published in 2021The rapid review was published in 2021.Summary of findings This rapid review focuses on adverse outcomes resulting from increased IPC measures put in place during the COVID-19 pandemic. Whilst there is some evidence to show that there may be a link between IPC measures and adverse outcomes, causation cannot be assumed.During the COVID-19 restrictions, the cognition, mental wellbeing and behaviour of residents in care homes were negatively affectedIncreased IPC procedures during the COVID-19 pandemic increased stress and burden among care staff because of increased workload and dilemmas between adhering well to IPC procedures and providing the best care for the care recipientsCOVID-19 IPC procedures were not well developed at the beginning of the COVID-19 pandemic, but evidence from 2021 suggests that good adherence to IPC measures can enable visitations by family members and medical professionals into care homesOnly one study investigating domiciliary care was found. Therefore, it is difficult to make conclusions related specifically to this care settingNo published studies have reported on the costs or cost-effectiveness of IPC measures or have explored the cost implications of adverse outcomes associated with IPC measuresBest quality evidence Only one study was deemed as high quality based on the quality appraisal checklist ranking. This was a mixed methods study design (Tulloch et al., 2021).Policy Implications Since March 2020, there have been many changes to government guidelines relating to procedures to keep the population safe from COVID-19 harm. Policies vary according to country, even within the UK. Important issues such as care home visitation policies have changed in such a way that care home staff have felt it difficult to keep up with the changes, which in itself increased the burden on those staff. The following implications were identified from this work:IPC policies should be clear, concise and tailored to care homes and domiciliary care settingsIncreased attention to workforce planning is needed to ensure adequate staffing and to reduce individual burdenRestrictions (e.g. visitation) for care home residents needs to be balanced by additional psychological supportFurther research with robust methods in this area is urgently needed especially in the domiciliary care settingStrength of Evidence One limitation is the lack of high-quality evidence from the included studies. Confidence in the strength of evidence about adverse outcomes of COVID-19 IPC procedures was rated as ‘low’ overall. Whilst the majority of studies achieved a ‘moderate’ score based on the quality appraisal tools used, due to the nature of the methods used, the overall quality of evidence is low.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis rapid review was funded by the Wales COVID-19 Evidence Centre (WCEC)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors